These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8661400)

  • 1. Neutralizing epitope on penetration protein of vaccinia virus.
    Ichihashi Y; Oie M
    Virology; 1996 Jun; 220(2):491-4. PubMed ID: 8661400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a vaccinia virus penetration protein.
    Ichihashi Y; Takahashi T; Oie M
    Virology; 1994 Aug; 202(2):834-43. PubMed ID: 8030246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Pannell LK; Lebowitz J; Fogg C; White CL; Moss B; Cohen GH; Eisenberg RJ
    Virology; 2005 Oct; 341(1):59-71. PubMed ID: 16083934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
    Hiramatsu K; Tadano M; Men R; Lai CJ
    Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B5r gene based sequence analysis of Indian buffalopox virus isolates in relation to other orthopoxviruses.
    Singh RK; Balamurugan V; Hosamani M; DE UK; Chandra BM; Krishnappa M P G
    Acta Virol; 2007; 51(1):47-50. PubMed ID: 17432943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid sequence determination of vaccinia virus immunodominant protein p35 and identification of the gene.
    Chertov OYu ; Telezhinskaya IN; Zaitseva EV; Golubeva TB; Zinov'ev VV; Ovechkina LG; Mazkova LB; Malygin EG
    Biomed Sci; 1991; 2(2):151-4. PubMed ID: 1772969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.
    Wolffe EJ; Vijaya S; Moss B
    Virology; 1995 Aug; 211(1):53-63. PubMed ID: 7645236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge.
    Pulford DJ; Gates A; Bridge SH; Robinson JH; Ulaeto D
    Vaccine; 2004 Sep; 22(25-26):3358-66. PubMed ID: 15308360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of the gene for the immunodominant p35 protein from vaccinia virus].
    Zinov'ev VV; Ovechkina LG; Matskova LV; Balakhnin SM; Malygin EG; Chertov OIu; Telezhinskaia IN; Zaĭtseva EV; Golubeva TB
    Mol Biol (Mosk); 1992; 26(1):142-9. PubMed ID: 1508163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
    Wojcik J
    Acta Microbiol Pol; 1995; 44(2):191-6. PubMed ID: 8906935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
    Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
    Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
    Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
    J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.
    Yoo D; Deregt D
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):297-302. PubMed ID: 11238212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The A17L gene product of vaccinia virus is exposed on the surface of IMV.
    Wallengren K; Risco C; Krijnse-Locker J; Esteban M; Rodriguez D
    Virology; 2001 Nov; 290(1):143-52. PubMed ID: 11882999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
    Zhang F; Yu M; Weiland E; Morrissy C; Zhang N; Westbury H; Wang LF
    Arch Virol; 2006 Jan; 151(1):37-54. PubMed ID: 16132176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal amino acid sequences of vaccinia virus structural proteins.
    Takahashi T; Oie M; Ichihashi Y
    Virology; 1994 Aug; 202(2):844-52. PubMed ID: 8030247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.